Another four lots of a diabetes drug recalled for having too much of a carcinogen

If you are taking this medication, please read the whole article for more information.

https://news.yahoo.com/another-two-lots-diabetes-drug-112731185.html

 

David J. Neal
,Miami Herald•November 3, 2020

Nostrum Laboratories announced Monday evening and Tuesday morning that four lots of its version of Type 2 diabetes drug metformin have too much of the carcinogen NDMA.

Nostrum becomes the latest of many drug makers, most recently Marksans Pharma Limited of India last month, to recall their metformin because the NDMA (N-Nitrosodimethylamine) content surpasses the FDA’s daily limit.

This covers 100-tablet bottles of 750 mg Metformin Hydrochloride Extended Release Tablets, lot Nos. MET200101 and MET200301; and 500 mg Metformin Hydrochloride Extended Release Tablets, lot Nos. MET100201 and MET100401. All recalled bottles have an expiration date of 05/2022.

Consumers should keep taking their metformin until their doctor or another medical professional comes up with another course of treatment.

•••••